Empowering Healthcare Professionals in Rare Disease Awareness through the Hidoc Dr. Platform: A Case Study on Hunter Syndrome Campaign

Hunter Syndrome, or Mucopolysaccharidosis II (MPSII), is a rare, progressive metabolic disorder caused by a deficiency in the enzyme iduronate-2-sulfatase, affecting approximately 0.69 to 1.19 per 100,000 live births. Timely diagnosis and intervention, particularly through Enzyme Replacement Therapy (ERT), are crucial for enhancing patient outcomes. This case study examines a digital campaign that utilized the Hidoc Dr. platform to increase disease awareness and educate healthcare professionals (HCPs) in India, with a focus on pediatricians, ENT specialists, and geneticists. Through a coordinated omnichannel approach—including apps, websites, webinars, email, and telecalling—the campaign achieved notable engagement metrics, surpassing its initial goals with 23,371 HCPs reached, 24,562 impressions, and a click-through rate (CTR) of 5%. These results demonstrate the effectiveness of digital engagement in educating HCPs on rare diseases like Hunter Syndrome, ultimately aiding early detection and management.